149 related articles for article (PubMed ID: 35842521)
1. Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system.
Linfield DT; Rothberg MB; Pfoh ER; Noss R; Cassard L; Powers JC; Lipold L; Martinez KA
Breast Cancer Res Treat; 2022 Sep; 195(2):153-160. PubMed ID: 35842521
[TBL] [Abstract][Full Text] [Related]
2. Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians.
White DB; Bonham VL; Jenkins J; Stevens N; McBride CM
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):2980-6. PubMed ID: 18990739
[TBL] [Abstract][Full Text] [Related]
3. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
Hull LE; Haas JS; Simon SR
Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
[TBL] [Abstract][Full Text] [Related]
4. Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Trivers KF; Baldwin LM; Miller JW; Matthews B; Andrilla CH; Lishner DM; Goff BA
Cancer; 2011 Dec; 117(23):5334-43. PubMed ID: 21792861
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Bellcross CA; Leadbetter S; Alford SH; Peipins LA
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):728-35. PubMed ID: 23371291
[TBL] [Abstract][Full Text] [Related]
6. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
7. Physicians' experiences with BRCA1/2 testing in community settings.
Keating NL; Stoeckert KA; Regan MM; DiGianni L; Garber JE
J Clin Oncol; 2008 Dec; 26(35):5789-96. PubMed ID: 19001322
[TBL] [Abstract][Full Text] [Related]
8. Uptake of testing for germline
Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
[TBL] [Abstract][Full Text] [Related]
9. Referral and experience with genetic testing among women with early onset breast cancer.
Brown KL; Hutchison R; Zinberg RE; McGovern MM
Genet Test; 2005; 9(4):301-5. PubMed ID: 16379543
[TBL] [Abstract][Full Text] [Related]
10. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
[TBL] [Abstract][Full Text] [Related]
11. Building the What Comes Next Cohort for
Dossa F; Metcalfe K; Sutradhar R; Little T; Eisen A; Chun K; Meschino WS; Velsher L; Ellis JL; Baxter NN
CMAJ Open; 2021; 9(3):E874-E885. PubMed ID: 34870614
[TBL] [Abstract][Full Text] [Related]
12. Recruiting African American women to participate in hereditary breast cancer research.
Halbert CH; Brewster K; Collier A; Smith C; Kessler L; Weathers B; Stopfer JE; Domchek S; Wileyto EP
J Clin Oncol; 2005 Nov; 23(31):7967-73. PubMed ID: 16258097
[TBL] [Abstract][Full Text] [Related]
13. Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system.
McCuaig JM; Care M; Ferguson SE; Kim RH; Stockley TL; Metcalfe KA
Gynecol Oncol; 2020 Sep; 158(3):747-753. PubMed ID: 32674931
[TBL] [Abstract][Full Text] [Related]
14. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
[TBL] [Abstract][Full Text] [Related]
15. Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
Boitano TKL; Barrington DA; Batra S; McGwin G; Turner TB; Farmer MB; Brown AM; Straughn MJ; Leath CA
Gynecol Oncol; 2019 Aug; 154(2):379-382. PubMed ID: 31196574
[TBL] [Abstract][Full Text] [Related]
16. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
17. Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
Lieberman S; Tomer A; Ben-Chetrit A; Olsha O; Strano S; Beeri R; Koka S; Fridman H; Djemal K; Glick I; Zalut T; Segev S; Sklair M; Kaufman B; Lahad A; Raz A; Levy-Lahad E
Genet Med; 2017 Jul; 19(7):754-762. PubMed ID: 27929526
[TBL] [Abstract][Full Text] [Related]
18. Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.
McCarthy AM; Bristol M; Fredricks T; Wilkins L; Roelfsema I; Liao K; Shea JA; Groeneveld P; Domchek SM; Armstrong K
Cancer; 2013 Oct; 119(20):3596-603. PubMed ID: 23861169
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
[TBL] [Abstract][Full Text] [Related]
20. BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.
Pal T; Vadaparampil S; Betts J; Miree C; Li S; Narod SA
Genet Test; 2008 Sep; 12(3):401-7. PubMed ID: 18752448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
